About Biocomposites
Biocomposites is a company based in Keele (United Kingdom) founded in 1999 by John Joseph Cooper, John Stephen Bratt, and Russell David Waters.. Biocomposites has raised $1.8 million across 2 funding rounds from investors including Novo Holdings and TA Associates. Biocomposites has completed 1 acquisition, including ARTOSS. Biocomposites operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, CartiHeal and Theradaptive, among others.
- Headquarter Keele, United Kingdom
- Founders John Joseph Cooper, John Stephen Bratt, Russell David Waters
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocomposites (Uk) Limited
- Date of Incorporation 06 Oct, 1999
- Jurisdiction NEWCASTLE, STAFFS
-
Annual Revenue
$53.36 M (USD)40as on Dec 31, 2016
-
Net Profit
$26.49 M (USD)0as on Dec 31, 2017
-
EBITDA
-
Total Equity Funding
$1.8 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Novo Holdings
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Biocomposites
Biocomposites has successfully raised a total of $1.8M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(31 Mar 2017)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Unspecified - Biocomposites | Valuation |
investors |
|
| Mar, 2017 | Amount | Unspecified - Biocomposites | Valuation | TA |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biocomposites
Biocomposites has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Novo Holdings and TA Associates. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by private equity firm TA.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biocomposites
Biocomposites has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ARTOSS. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Orthopedic and dental devices are distributed by ARTOSS.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biocomposites
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocomposites Comparisons
Competitors of Biocomposites
Biocomposites operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, CartiHeal and Theradaptive, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Implants for bone and cartilage regeneration are developed and provided.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biocomposites
Frequently Asked Questions about Biocomposites
When was Biocomposites founded?
Biocomposites was founded in 1999 and raised its 1st funding round 18 years after it was founded.
Where is Biocomposites located?
Biocomposites is headquartered in Keele, United Kingdom. It is registered at Keele, England, United Kingdom.
Is Biocomposites a funded company?
Biocomposites is a funded company, having raised a total of $1.8M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $1.8M, raised on Mar 31, 2017.
What is the annual revenue of Biocomposites?
Annual revenue of Biocomposites is $53.36M as on Dec 31, 2016.
What does Biocomposites do?
Developer of synthetic calcium composite products for bone repair and regeneration. The products include STIMULAN an absorbable calcium sulfate designed to be placed directly at the site of infection in bone and soft tissues. genex ia a synthetic bone graft substitute aimed at supporting natural bone healing, Biosteon is an osteoconductive calcium phosphate composite, AllogranR Bilok used in trauma, spine, and sports injury applications, and NanoBone SBX PuttyQD is a nanostructured hydroxyapatite grafts cleared for interbody spinal fusion.
Who are the top competitors of Biocomposites?
Biocomposites's top competitors include EpiBone, Theradaptive and MiMedx Group.
How many acquisitions has Biocomposites made?
Biocomposites has made 1 acquisition, including ARTOSS.
Who are Biocomposites's investors?
Biocomposites has 2 investors. Key investors include Novo Holdings, and TA Associates.
What is Biocomposites's valuation?
The valuation of Biocomposites is $35.14M as of Mar 2017.